Authors:
Bauserman, RL
Ward, MA
Eldred, L
Swetz, A
Citation: Rl. Bauserman et al., Increasing voluntary HIV testing by offering oral tests in incarcerated populations, AM J PUB HE, 91(8), 2001, pp. 1226-1229
Authors:
Bell, AW
Ward, MA
Blackstock, WP
Freeman, HNM
Choudhary, JS
Lewis, AP
Chotai, D
Fazel, A
Gushue, JN
Paiement, J
Palcy, S
Chevet, E
Lafreniere-Roula, M
Solari, R
Thomas, DY
Rowley, A
Bergeron, JJM
Citation: Aw. Bell et al., Proteomics characterization of abundant Golgi membrane proteins, J BIOL CHEM, 276(7), 2001, pp. 5152-5165
Authors:
O'Neill, MJ
Hicks, CA
Ward, MA
Osborne, DJ
Wishart, G
Mathews, KS
McLaughlin, DP
Stamford, JA
McCarty, DR
Patrick, KE
Roman, C
Fleisch, JH
Gilmore, J
Boot, JR
Citation: Mj. O'Neill et al., LY393615, a novel neuronal Ca2+ and Na+ channel blocker with neuroprotective effects in models of in vitro and in vivo cerebral ischemia, BRAIN RES, 888(1), 2001, pp. 138-149
Authors:
O'Neill, MJ
Bogaert, L
Hicks, CA
Bond, A
Ward, MA
Ebinger, G
Ornstein, PL
Michotte, Y
Lodge, D
Citation: Mj. O'Neill et al., LY377770, a novel iGlu5 kainate receptor antagonist with neuroprotective effects in global and focal cerebral ischaemia, NEUROPHARM, 39(9), 2000, pp. 1575-1588
Authors:
Bond, A
Jones, NM
Hicks, CA
Whiffin, GM
Ward, MA
O'Neill, MF
Kingston, AE
Monn, JA
Ornstein, PL
Schoepp, DD
Lodge, D
O'Neill, MJ
Citation: A. Bond et al., Neuroprotective effects of LY379268, a selective mGlu2/3 receptor agonist:Investigations into possible mechanism of action in vivo, J PHARM EXP, 294(3), 2000, pp. 800-809
Citation: Ca. Hicks et al., Neuroprotective effects of the neuronal Ca2+ channel blockers, LY042826 and LY393615 in vivo, EUR J PHARM, 408(3), 2000, pp. 241-248
Authors:
O'Neill, MJ
Murray, TK
McCarty, DR
Hicks, CA
Dell, CP
Patrick, KE
Ward, MA
Osborne, DJ
Wiernicki, TR
Roman, CR
Lodge, D
Fleisch, JH
Singh, J
Citation: Mj. O'Neill et al., ARL 17477, a selective nitric oxide synthase inhibitor, with neuroprotective effects in animal models of global and focal cerebral ischaemia, BRAIN RES, 871(2), 2000, pp. 234-244
Authors:
Bond, A
Ragumoorthy, N
Monn, JA
Hicks, CA
Ward, MA
Lodge, D
O'Neill, MJ
Citation: A. Bond et al., LY379268, a potent and selective Group II metabotropic glutamate receptor agonist, is neuroprotective in gerbil global, but not focal, cerebral ischaemia, NEUROSCI L, 273(3), 1999, pp. 191-194
Authors:
Sirbaugh, PE
Pepe, PE
Shook, JE
Kimball, KT
Goldman, MJ
Ward, MA
Mann, DM
Citation: Pe. Sirbaugh et al., A prospective, population-based study of the demographics, epidemiology, management, and outcome of out-of-hospital pediatric cardiopulmonary arrest, ANN EMERG M, 33(2), 1999, pp. 174-184
Authors:
Hicks, CA
Ward, MA
Swettenham, JB
O'Neill, MJ
Citation: Ca. Hicks et al., Synergistic neuroprotective effects by combining an NMDA or AMPA receptor antagonist with nitric oxide synthase inhibitors in global cerebral ischaemia, EUR J PHARM, 381(2-3), 1999, pp. 113-119
Authors:
Bond, A
Lodge, D
Hicks, CA
Ward, MA
O'Neill, MJ
Citation: A. Bond et al., NMDA receptor antagonism, but not AMPA receptor antagonism attenuates induced ischaemic tolerance in the gerbil hippocampus, EUR J PHARM, 380(2-3), 1999, pp. 91-99
Authors:
Stamford, JA
Isaac, D
Hicks, CA
Ward, MA
Osborne, DJ
O'Neill, MJ
Citation: Ja. Stamford et al., Ascorbic acid is neuroprotective against global ischaemia in striatum but not hippocampus: histological and voltammetric data, BRAIN RES, 835(2), 1999, pp. 229-240
Authors:
Hicks, CA
Ward, MA
Ragumoorthy, N
Ambler, SJ
Dell, CP
Dobson, D
O'Neill, MJ
Citation: Ca. Hicks et al., Evaluation of glycine site antagonists of the NMDA receptor in global cerebral ischaemia, BRAIN RES, 819(1-2), 1999, pp. 65-74